SINUS TARSI SYNDROME

SINUS TARSI SYNDROME was reported 28 times

These drug classes are most commonly taken by patients reporting SINUS TARSI SYNDROME:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 6
1 Vitamin D [EPC] 6
2 Estrogen [EPC] 4
3 Fluoroquinolone Antibacterial [EPC] 3
4 Platelet Aggregation Inhibitor [EPC] 3
5 Proton Pump Inhibitor [EPC] 3
6 Vitamin C [EPC] 3
7 Amino Acid [EPC] 2
8 Aminosalicylate [EPC] 2
9 Aromatase Inhibitor [EPC] 2
10 Arteriolar Vasodilator [EPC] 2
11 Calcium [EPC] 2
12 Dietary Cholesterol Absorption Inhibitor [EPC] 2
13 Erythropoiesis-stimulating Agent [EPC] 2
14 Estrogen Receptor Antagonist [EPC] 2
15 Expectorant [EPC] 2
16 GLP-1 Receptor Agonist [EPC] 2
17 HMG-CoA Reductase Inhibitor [EPC] 2
18 Histamine-1 Receptor Antagonist [EPC] 2
19 Histamine-2 Receptor Antagonist [EPC] 2
20 Leukocyte Growth Factor [EPC] 2
21 Nucleoside Metabolic Inhibitor [EPC] 2
22 Amide Local Anesthetic [EPC] 1
23 Angiotensin 2 Receptor Blocker [EPC] 1
24 Antiarrhythmic [EPC] 1
25 Antimetabolite [EPC] 1
26 Barbiturate [EPC] 1
27 Benzodiazepine [EPC] 1
28 Central Nervous System Stimulant [EPC] 1
29 Central alpha-2 Adrenergic Agonist [EPC] 1
30 Complement Inhibitor [EPC] 1
31 Ester Local Anesthetic [EPC] 1
32 Glycopeptide Antibacterial [EPC] 1
33 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
34 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
35 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
36 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
37 Insulin Analog [EPC] 1
38 Interferon beta [EPC] 1
39 Methylxanthine [EPC] 1
40 Non-Standardized Chemical Allergen [EPC] 1
41 Progestin [EPC] 1
42 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
43 Thiazide Diuretic [EPC] 1
44 Vitamin B12 [EPC] 1